[Reversal effect of LBH589 alone or in combination with bortezomib on drug-resistance in myeloid leukemia and its mechanism].

Jiang, Xue-Jie; Meng, Fan-Yi; Zhou, Hong-Sheng; Wang, Qiang; Wu, Fu-Qun; Huang, Kai-Kai; Huang, Ming; Wang, Zhi-Xiang; Chen, Wei-Wei

Jiang, Xue-Jie; Meng, Fan-Yi; Zhou, Hong-Sheng; Wang, Qiang; Wu, Fu-Qun; Huang, Kai-Kai; Huang, Ming; Wang, Zhi-Xiang; Chen, Wei-Wei.

Affiliation

Jiang XJ; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515 China.

Zhonghua Xue Ye Xue Za Zhi ; 32(8): 537-42, 2011 Aug.

Article in Zh | MEDLINE | ID: mdl-22338177

Subject(s)

Antineoplastic Agents/pharmacology; Apoptosis/drug effects; Boronic Acids/pharmacology; Cell Proliferation/drug effects; Hydroxamic Acids/pharmacology; Pyrazines/pharmacology; Bortezomib; Drug Resistance, Neoplasm/drug effects; Drug Synergism; HL-60 Cells/drug effects; Humans; Indoles; Leukemia, Myeloid/genetics; Leukemia, Myeloid/metabolism; Panobinostat; Signal Transduction/drug effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Boronic Acids / Apoptosis / Cell Proliferation / Hydroxamic Acids / Antineoplastic Agents Limits: Humans Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2011 Type: Article

Search on Google

XML

PubMed Links